Long COVID has emerged as a significant global health concern. While the acute phase of the disease is well-documented, the persistent nasal symptoms ...

Looking beyond jabs, sprays or tablets, scientists are thinking outside the box for delivering antiviral medication to ...

Delve into the landscape of biotech companies developing treatments for HIV and find out if we are getting closer to a cure.

Recognizing early body signals helps distinguish viral from bacterial infections and avoid unnecessary meds or doctor visits.

Medical News Today looks at four recent studies to examine which aspects of health and behavior can influence a person's risk of developing dementia, including sleep, vaccines, and cholesterol levels ...

A team has identified a previously unknown phase of the immune response. The results challenge long-standing assumptions about the process called 'T-cell priming'. These new insights have significant ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine ...

Researchers had been studying the green alga Chlamydomonas reinhardtii for decades without seeing evidence of an active virus within it -- until researchers not only found a virus in the alga but ...

Early infection incidence in patients with multiple myeloma following treatment with cilta-cel infusion highlights the ...

The capitalist response to the pandemic has exacted a stark toll of mass death and disability, while accelerating social ...

The research teams led by Wolfgang Kastenmüller and Georg Gasteiger utilized advanced microscopy techniques to investigate ...